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Abstract
Characterization of protein modification by phosphorylation is one of the major tasks that have to
be accomplished in the post-genomic era. Phosphorylation is a key reversible modification
occurring mainly on serine, threonine and tyrosine residues that can regulate enzymatic activity,
subcellular localization, complex formation and degradation of proteins. The understanding of the
regulatory role played by phosphorylation begins with the discovery and identification of
phosphoproteins and then by determining how, where and when these phosphorylation events
take place. Because phosphorylation is a dynamic process difficult to quantify, we must at first
acquire an inventory of phosphoproteins and characterize their phosphorylation sites. Several
experimental strategies can be used to explore the phosphorylation status of proteins from
individual moieties to phosphoproteomes. In this review, we will examine and catalogue how
proteomics techniques can be used to answer specific questions related to protein
phosphorylation. Hence, we will discuss the different methods for enrichment of phospho-proteins
and -peptides, and then the various technologies for their identification, quantitation and validation.
Background
Post-translational modifications of proteins are consid-
ered to be one of the major determinants regarding organ-
isms complexity [1]. To date, at least more than 200
different types of post translational modifications (PTM)
have been identified of which only a few are reversible
and important for the regulation of biological processes.
One of the most studied PTM is protein phosphorylation,
because it is vital for a large number of protein functions
that are important to cellular processes spanning from sig-
nal transduction, cell differentiation, and development to
cell cycle control and metabolism. A primary role of phos-
phorylation is to act as a switch to turn "on" or "off" a pro-
tein activity or a cellular pathway in an acute and
reversible manner [2]. Furthermore, it is estimated that
one of every three proteins is phosphorylated at some
point in its life cycle [3]. Today, it is well-known that
almost all processes regulated by protein phosphorylation
are reversible and controlled by the combined action of
two different classes of enzymes, namely protein kinases
and phosphatases. These kinases and phosphatases, con-
stitute about 2% of the human genome [1,4,5].
Analysis of the entire cellular phosphoproteins panel, the
so-called phosphoproteome, has been an attractive study
subject since the discovery of phosphorylation as a key
regulatory mechanism of cell life. But despite a growing
knowledge of many phosphorylation consensus
sequences, this PTM cannot usually be predicted accu-
rately from the translated gene sequence alone. Thus, the
experimental determination of phosphorylation sites is
an important task. To this end, the development and opti-
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mization of protocols for the enrichment of phosphor-
ylated proteins or peptides is essential. In addition,
various methods for protein phosphorylation site deter-
mination have been developed, yet this task remains a
technical challenge [6]. Well established methods involv-
ing the analysis of 32P-labeled phosphoproteins by
Edman degradation and two-dimensional phosphopep-
tide mapping have proven to be powerful but not without
limitations. Beyond the inconvenience associated to the
use of radioactivity, these traditional phosphorylation
analysis methods can be time-consuming and are not well
suited for the high throughput pipelines required for
phosphoproteome analysis. Consequently, mass spec-
trometry has emerged as a reliable and sensitive method
for the characterization of protein phosphorylation sites
[7] and may therefore represent a method of choice for the
analysis of protein phosphorylation [8].
Unfortunately, phosphoproteins analysis is not straight-
forward for five main reasons. First, the stoichiometry of
phosphorylation is generally relatively low, because only
a small fraction of the available intracellular pool of a pro-
tein is phosphorylated at any given time as a result of a
stimulus. Second, the phosphorylatation sites on proteins
might vary, implying that any given phosphoprotein is
heterogeneous (i.e. it exists in several different phosphor-
ylated forms). Third, many of the signaling molecules,
which are major targets of phosphorylation events [9], are
present at low abundance within cells and, in these cases;
enrichment is a prerequisite before analysis. Fourth, most
analytical techniques used for studying protein phospho-
rylation have a limited dynamic range, which means that
although major phosphorylation sites might be located
easily, minor sites might be difficult to identify. Finally,
phosphatases could dephosphorylate residues unless pre-
cautions are taken to inhibit their activity during prepara-
tion and purification steps of cell lysates.
In this review, we present at first a survey of methods
available to identify phosphoproteins and phosphopep-
tides and to map the precise phosphorylated residues and
secondly, we enumerate methodologies available to
quantitate and validate the identified phosphorylation
sites/events.
Review
The identification of phosphoproteins and the characteri-
zation of their phosphorylation sites was greatly
improved by the introduction of mass spectrometry, but
only a fraction of the proteins in a proteome are phospho-
rylated at any given time. Some of the most commonly
used methods for enrichment of phosphoproteins or
phosphopeptides, when limiting amounts are available,
will now be discussed. These steps can be coupled to var-
ious analytical methods for detection and micro-charac-
terization. An overview of the experimental workflow
described below is presented in Figure 1.
Phosphoprotein separation and detection
Two-dimensional gel electrophoresis (2-DGE)
Normally, for separation by 2-DGE, proteins are subjected
to isoelectric focusing and separated by size. Using this
approach, a cell extract is prepared from two different
samples and resolved by 2-DGE for comparison of protein
expression or changes in protein modification by compar-
ison of the two corresponding gels. Currently, 2-D PAGE
is the only method capable of simultaneously resolving
several thousands of proteins [10,11] including protein
variants produced by the co- or post-translational process-
ing such as phosphorylation, glycosylation, and sulfation
[12]. The phosphorylation of a protein leads to a decrease
in its pI and consequently its coordinates in a 2-D gel. To
map phosphoproteins on 2-DGE, it has been exploited
this fact to discriminate phosphoproteins from nonphos-
phoproteins. Although this method can provide valuable
information, it suffers from many limitations, including
poor protein representation and an inability to identify
low-copy proteins [13,14]. Another limitation to 2-DGE
resides in the fact that only some proteins with molecular
weight between 10 and 100 kDa are visualized. Further-
more, 2-DGE is poorly suitable to resolve integral mem-
brane proteins due to proteins aggregation during the first
isoelectric-focusing (IEF) migration. Thus, the limitations
of 2-DGE have inspired the development of several meth-
ods (see below).
Immunoblot
Immuno- or Western blot is a technique [15] which
requires the availability of specific antibodies to detected
proteins transferred from a one-dimensional gel electro-
phoresis (1-DGE) or 2-DGE [16] to a solid membrane
support. The development of antibodies against common
protein epitopes allows the identification of proteins shar-
ing the same characteristics such as phosphorylated pro-
teins. For phosphoproteome analysis phosphoserine,
phosphothreonine and phosphotyrosine represent the
common epitopes which are recognized by specific anti-
bodies that are routinely employed. Analysis of phospho-
proteome using Western blot is improved by combining
2-DGE with highly selective anti-phosphoantibodies [17].
While excellent anti-phosphotyrosine antibodies are
available, better anti-phosphoserine and anti-phospho-
threonine antibodies are currently needed. This is proba-
bly one of the major reasons why tyrosine
phosphorylation, which is much less frequent in cells
than serine/threonine phosphorylation, is much more
studied [18-20]. Although Western blot allows the detec-
tion of very low abundance phosphoproteins, this
method is not very suitable for quantitative analysis due
to the variability of the amount of proteins transferred toProteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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Schematic representation of phosphoprotein analysis workflow Figure 1
Schematic representation of phosphoprotein analysis workflow. The most commonly used methods to resolve, to 
purify or to enrich phosphoproteins are described in the Protein separation section. Peptides resulting from trypsin diges-
tion of phosphoproteins may be analyzed directly by MS or by Edman degradation. Other approaches may be used for the 
enrichment of phosphopeptides. These methods are depicted in the Peptide separation section. MALDI and ESI are usually 
used for identification of phosphoproteins. The two predominant techniques for idenditification of the precise sites of phos-
phorylation are i) Edman degradation and ii) MS analysis (Neutral loss and Precursor ion). These methods are described in the 
Identification section. 1D/2D GE: On-dimensional/Two-dimensional gel electrophoresis. Chem. Modif.: Chemical Modifi-
cation. ESI: Electrospray Ionisation. Ib: Immunoblot. IMAC: Immobilized Metal Affinity Chromatography. Ip-α PY: Immunop-
urification using a phospho-tyrosine antibody. LC: Liquid Chromatography. MALDI: Matrix-Assisted Laser Desorption 
Ionization. ProQ: Pro-Q Diamond™. AR: Autoradiography. β-Elemin: β-elimination reaction.
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the membrane. In addition, the selectivity and affinity
characteristics of the antibodies are of major importance
since a large number of "false positive" interactions may
be detected, thus reducing the applicability of this
approach.
Direct staining
The apparently easiest way to analyze phosphoproteome
of cells, tissues or organisms is to employ reagents
designed to selectively detect phosphoproteins directly in
1- or 2-DGE. Since 1970 several methods have been
described [21,22] to stain phosphoproteins directly in
gels but their low specificity and sensitivity prevented
those methods from being routinely applied. Recently, a
fluorescent phosphosensor dye, Pro-Q Diamond™ has
been developed [23]. This dye can discriminate between
phosphorylated and unphosphorylated proteins and is
reversible. In addition, it is compatible with protein dyes
such as SYPRO Ruby. Pro-Q Diamond™ combined to
SYPRO Ruby dye allows first, to detect phosphorylated
proteins (Pro-Q Diamond™) and total proteins (SYPRO
Ruby) on the same gel and second, to distinguish between
a slightly phosphorylated from high abundant protein
and a highly phosphorylated from a low abundant pro-
tein by comparing the results of the two different colora-
tions[24,25]. This dye permits phosphoproteins
identification in a complex protein mixture with sensitiv-
ity in the ng/ml range. Although this sensitivity is signifi-
cantly good, it is however not sufficient for
comprehensive analysis of the phosphoproteome.
Protein phosphatases
Phosphorylation of proteins leads to a change of the net
charge of proteins and thus the migration behavior during
2-DGE. Accordingly, the charge variation occurring after
phosphatase treatment can be exploited to discriminate
phosphorylated from unphosphorylated proteins. Phos-
phatase treated and untreated samples are analyzed by 2-
DGE and the resulting 2D maps compared in order to
detect differences in migration corresponding to phos-
phorylated proteins. This experimental strategy capitalizes
on the specific enzymatic activity of k-phosphatase
(kPPase) on phosphoserine, phosphothreonine, phos-
photyrosine and phosphohistidine residues [26]. An
improvement of this experimental strategy was recently
achieved by employing difference gel electrophoresis
(DIGE) technology for the detection of variations in pro-
tein migration after kPPase treatment [27]. Since DIGE
eliminates gel-to-gel variability thus allowing separation
of two proteomes on the same gel, detection of changes in
protein patterns is greatly facilitated. The phosphatase-
based method allows an easy identification of phosphor-
ylated proteins expressed in a sample but it is less suitable
for the quantification of variations of protein phosphor-
ylation patterns comparing two different samples. The
complexity of the analysis and the variability of the effi-
cacy of enzymatic action are the main reasons for this.
Isotopic labeling
Protein labeling with either inorganic phosphate (32Pi) in
vivo or γ-(32P)-ATP in vitro is still one of the most practical
way to study protein phosphorylation [28-33]. Separation
of labeled proteins by 1- or 2-DGE and autoradiography
or image acquisition by PhosphorImager systems for vis-
ualization of phosphorylated proteins is the most com-
mon workflow pursued in proteomics studies when an
isotopic labeling strategy is considered.
Analysis of protein phosphorylation in vivo
In this approach, cells are labeled in vivo with 32P-ortho-
phosphate in pulse or pulse-chase experiments in cell/tis-
sue culture [34,35]. Then, cell extracts are prepared and
analyzed. The in vivo phosphorylation, while more physi-
ologically relevant by avoiding the possibility of non-spe-
cific phosphorylation, requires working with significantly
larger amounts of radioactivity due to the extensive cellu-
lar consumption of phosphate in the form of phospho-
proteins, nucleic acids, phospholipids, etc. However, in
vivo radiolabeling has limitations: (i) 32P-labeling is inef-
ficient because of the high concentrations of non-radioac-
tive endogenous ATP; (ii) although many
phosphoproteins can be visualized by autoradiography,
they are not present in sufficient amounts to be identified,
and (iii) the use of a cell/tissue culture.
Protein kinase profiling in vitro
Protein kinase profiling is a way to identify protein
kinases and of course, their substrates under various bio-
logical conditions. In this strategy, radiolabeled phospho-
proteins are generated in vitro, using γ-32P-ATP and either
purified protein kinase or cell lysates, and then are ana-
lyzed [36,37]. The advantage of studying in vitro phospho-
rylation is the theoretical goal 100% phosphorylation
stoichiometry. However, in vitro phosphorylation has lim-
itations in that phosphorylation sites may differ from
what might take place in vivo. Thus, the big disadvantage
is the burden of proof that the phosphorylation sites
found are real and relevant physiologically. As a conse-
quence, the results must, in general, be confirmed by in
vivo studies.
Phosphoproteome enrichment and 
identification
The limitations of gel electrophoresis have inspired the
development of methods to circumvent protein gels
entirely. In one such method, the entire protein mixture
isolated from cells is converted to peptides, which are
then resolved by liquid chromatography. Following sepa-
ration, the peptides are injected directly into a mass spec-
trometer in an "on-line" configuration for mass analysisProteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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and protein identification. A variety of techniques have
emerged using this general strategy, including multidi-
mensional liquid chromatography [38], cation-exchange
and reverse-phase chromatography [39], and liquid chro-
matography combined with ion mobility spectrometry
and tandem mass spectrometry (LC-IMS-TOF-MS/MS)
[40]. The advantage of these methods is that, theoretically,
more proteins can be identified, especially low-copy pro-
teins. However, protein gels perform an important func-
tion in that they allow for the visual selection of specific
proteins from a complex mixture.
Methods for phosphoproteome enrichment
A major obstacle in the study of phosphorylated proteins
is that they comprise only a small fraction of the total pro-
tein in a cellular lysate. Thus, many phosphoproteins can-
not be identified in a cell extract. As a consequence, a
number of techniques have been developed to partially
purify or to preferentially enrich phosphopeptides from a
complexe mixture, namely i) Immobilized Metal Affinity
Chromatography (IMAC); ii) Specific chemical derivatiza-
tion; and iii) Immunoprecipitation.
Immobilized Metal Affinity Chromatography (IMAC)
The use of (miniaturized) immobilized metal affinity
chromatography (IMAC) columns was developed for the
enrichment of phosphopeptides and exploits the high
affinity of a phosphate group to cations such as Zn2+, Fe3+,
and Ga3+ [41,42]. IMAC has been successfully used either
in off-line or on-line formats for the detection of phos-
phopeptides using MS [42-45]. Although this approach is
useful, it does have a problem in that it is not absolutely
specific because peptides that contain many acidic amino-
acids, histidine or cysteine co-elute [46]. In addition, mul-
tiply phosphorylated peptides are more enriched and the
recovery of phosphopeptides appears to be largely
dependent on the type of metal ion, column material and
the elution procedure used. Other IMAC approach has
permitted a much higher specificity using esterification of
acidic residues before IMAC enrichment [47]. This way
eliminated the non-specific binding, and enabled the
determination of a large number of phosphorylation sites
on proteins from whole-cell lysates. Moreover, this
approach requires that all phosphoproteins in a cell lysate
have to be analyzed to detect those that undergo changes.
Recently, Larsen and colleagues reported the use of Tita-
nium dioxide (TiO2) as a potent chelator for phosphopep-
tides which may be used upstream of mass spectrometry
sequencing [48]. In this work, the authors attributed the
selective enhancement of phosphorylated peptide bind-
ing by dihydroxybenzoic acid to an effective competition
predominantly with non-phosphorylated peptides for
binding sites on TiO2. This effect was thought to be
achieved by the existence of a heterogeneous array of
adsorption sites on TiO2. In direct comparison with
IMAC, this procedure proved superior in terms of selectiv-
ity and sensitivity of phosphorylated peptide binding
[48]. In addition, the TiO2 purification was fast and can be
used in combination with high performance liquid chro-
matography coupled to either MALDI-MSMS or ESI-
MSMS.
Specific chemical derivatization
One approach to isolate phosphorylated proteins or pep-
tides is to take advantage of the unique chemistry of phos-
phoamino acids in peptides. To date, two methods have
been reported that use chemical modification of the phos-
phate moiety as a strategy to enrich phosphopeptides
from complex mixtures. The first method uses a β-elimi-
nation reaction that occurs when phosphoserine and
phosphothreonine residues are exposed to strong alkaline
conditions [49,50]. The resulting dehydroalanine or
dehydroaminobutyric acid residues can be detected, after
chemical modification with ethanethiol (EDT), using tan-
dem mass spectrometry (MS/MS) [51,52]. The same strat-
egy can be used to attach biotinylated moieties to purify
phosphoproteins or peptides. Thus, EDT is used as a
nucleophile, which provides a new reactive thiol group
serving as a linker for attachment of a biotinylated affinity
tag [49]. However, an undesired side effect involving side
chains on cysteine and methionine residues can still
occur. To overcome this problem, the sample is first
treated with performic acid, leading to oxidation of these
residues, thereby inactivating them. The second method is
an alternate strategy to isolate phosphotyrosine-contain-
ing peptides in addition to those containing phosphoser-
ine and phosphothreonine residues [53]. The main
feature of this method is that a transient carbodiimide
[ethyl carbodiimide (EDC)] catalyzes the addition of
cystamine to phosphate moieties, which then allows puri-
fication of phosphopeptides on glass beads containing
immobilized iodoacetyl groups. Elution of phosphopep-
tides is performed by cleavage of phosphoroamidate
bonds by trifluoroacetic acid. The main disadvantage of
these two methods is that the current chemistries require
significant amounts of protein or peptide for identifica-
tion by MS to be successful. In addition, the selectivity of
these methods has not been confirmed yet. Several pro-
teins were isolated using these methods that are not
known phosphoproteins. Nevertheless, these approaches
are promising and could be coupled to other fractionation
steps to improve the overall recovery of low-abundance
proteins.
Immunoprecipitation
Antibodies are routinely used to immunoprecipitate spe-
cific proteins. Consequently, phospho-specific antibodies
can be used to selectively immunoprecipitate phosphor-
ylated proteins depending on the specificity of the anti-
body. As for Western blot (see above) anti-Proteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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phosphotyrosine antibodies are the most reliably and
widely used in order to enrich tyrosine-phosphorylated
proteins from complex mixtures. These antibodies can be
used to immunoprecipitate, and therefore to enrich, tyro-
sine phosphorylated proteins from complex mixtures of
proteins such as cell lysates. Although these antibodies
have been relatively effective at enriching and identifying
low-abundance tyrosine phosphorylated proteins
[54,55], it has been showed that the existing immunopu-
rification protocols for phospho-tyrosine (pY) containing
peptides have a poor selectivity [19]. Recently, a method
using a pY antibody for pY peptide purification from an
enzymatically digested protein extract combined with LC-
MS/MS was applied to large scale pY analysis in cancer
cells [20]. Currently, there are no antibodies that are suit-
able for enriching proteins that are phosphorylated on
serine or threonine residues, and thus these proteins must
be enriched using the alternative methods described
above.
Methods for phosphoproteome identification
The use of mass spectrometry (MS) in protein phosphor-
ylation site determination has increased significantly in
the past few years and is now the dominant technology for
protein identification. However, the success of protein
identification depends on both the sample preparation
and the type of mass spectrometer used. The two most
common methods used for mass spectrometry are the
matrix-assisted laser desorption ionization (MALDI) and
the electrospray ionization (ESI) or the combination of
both. It is evident that in most cases multiple techniques
used in combination have been necessary for phospho-
proteins analysis and that no single combination of
approaches appears to be optimal for all proteins.
Mass spectrometry (MS)
Phosphorylation analysis by mass spectrometry is gener-
ally accomplished by a two-step approach. The phospho-
protein of interest is proteolytically digested, usually with
trypsin, and the tryptic peptides are analyzed to determine
which are phosphorylated. Then those phosphopeptides
are further analyzed, usually by tandem mass spectrome-
try (MS/MS), to determine the precise location of the
phosphorylation site(s). Phosphopeptides may be identi-
fied simply by examination of the list of observed peptide
masses for mass increases of 80 Da (the added mass of the
phosphate group) compared with the list of expected pep-
tide masses. Although this method is relatively straightfor-
ward, it also misses many phosphorylated peptides
because: i) The peptide maps are frequently incomplete
even for non-phosphorylated proteins; ii) The increased
acidity of the phosphate group generally results in
decreased ionization efficiency of a peptide [56]; and iii)
The competition for ionization of peptides in a mixture
results in suppression of signal for some peptides. None-
theless the ease and small amount of sample required for
a simple peptide map make this method popular. Using
β-elimination/Michael addition chemistry to replace the
phosphate with a chemical group more conducive to effi-
cient ionization can ameliorate some of the difficulties
associated with phosphopeptides [57].
Phosphopeptide mass measurement may be achieved by
MALDI, ESI or the combination of both. These processes
are the two most common ways to ionize peptides, yet
they differ fundamentally. For this reason, one may often
find some proteins ionize better by one process than the
other.
One approach to reduce the sample required for ESI meas-
urement is to reduce the fluid flow by use of small capil-
lary electrospray emitter tips, a process known as
nanoelectrospray. Nanoelectrospray produces a constant
signal for 10–30 min for a 1 μl sample, and the low flow
has been shown to increase the ionization efficiency and
reduce ion suppression [58]. Another way to reduce ion
suppression phenomena is to separate the peptides prior
to ionization. The common method is LC-MS, which has
the added benefit of concentrating dilute samples and
removing salt that interferes with the ionization process.
As a way to highlight the presence of phosphopeptides in
a mixture or to confirm the identity of a phosphopeptide,
a simple phosphatase reaction will cause a downward
shift in mass of 80 Da (or multiples of 80) for each phos-
phopeptide [59].
Database searching
Using data produced by mass spectrometers, proteins can
be identified by searching DNA and protein-sequence
databases. The success of protein identification depends
on the type of data utilized, the type of search conducted,
and the databases searched: i) Peptide Mass Fingerprint
Database Searching is used for peptide masses obtained
from MALDI-MS, which are compared against theoretical
spectra obtained from primary-sequence databases; ii)
Peptide mass tag database searching can be conducted
using peptide sequence obtained from MS/MS. In this
approach, a partial amino acid sequence, known as the
sequence tag, is combined with the mass of the peptide to
search relevant databases [60] and iii) the FASTS program
uses amino acid sequence obtained from MS/MS to search
databases from organisms whose genomes have not been
sequenced completely or whose databases are not fully
annotated [61].
Phosphorylation site mapping
In addition to identifying phosphoproteins, it is impor-
tant to characterize/map their phosphorylation sites. Such
data can provide information about the function of the
phosphorylation event as well as the nature of the kinaseProteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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responsible for this phosphorylation. The two predomi-
nant techniques for phosphorylation site identification
are i) Edman degradation and ii) MS analysis.
Edman degradation
Edman degradation is still one of the most practical meth-
ods to determine phosphorylation sites in peptides [62-
64]. This is because the technique is relatively simple, very
sensitive, and can be applied to a large variety of peptides
[28,31,65]. If enough radioactivity can be incorporated
into the phosphoprotein of interest, sites can be deter-
mined at the sub-fmol level. In this approach, a 32P-
labeled protein is digested with a protease and the result-
ing phosphopeptides are purified by reverse-phase HPLC
or thin-layer chromatography (TLC). The isolated pep-
tides then are cross-linked via their C-termini to an inert
membrane and the radioactive membrane is subjected to
several rounds of Edman cycles. The radioactivity is col-
lected after each cleavage step and the released 32P is
measured in a scintillation counter. This method posi-
tionally places the phosphoamino acid within the
sequenced phosphopeptide. Of course, this is meaningful
only if the sequence of the phosphopeptide is known.
This method is not any more quantitative beyond 30
Edman cycles. In addition, the need for a large amount of
starting material (more than pmol amounts of protein)
and the length of time to completion has made this pro-
cedure prohibitive to high throughput studies of the phos-
phoproteome. However, MacDonald et al. have extended
the usefulness of phosphorylation site characterization by
Edman chemistry through the development of the cleaved
radioactive peptide (CRP) program [66]. In CRP analysis,
one requires only that the sequence of the protein to be
known. Purification and sequencing of individual pep-
tides is not required. Radiolabeled proteins are cleaved at
predetermined residues by the action of a protease. The
phosphopeptides are then separated by HPLC or TLC,
cross-linked to the inert membrane, and carried through
25–30 Edman cycles. The sequence of the target protein is
entered into the CRP program. This program predicts how
many Edman cycles are required to cover 100% of the ser-
ines, threonines, and tyrosines from the site of cleavage.
However, this methodology is still very low-throughput
and require protein radiolabeling with 32P.
MS analysis
Phosphorylation sites in peptides can also be analyzed by
MS/MS. In this approach, the phosphopeptide is
sequenced in the mass spectrometer and the site of phos-
phorylation is determined unambiguously. Precursor ion
and neutral loss scanning are currently the methods of
choice for sequencing phosphopeptides [58,67-70].
Precursor ion scanning
On fragmentation by collision-induced dissociation
(CID) in a tandem mass spectrometer, phosphopeptides
not only produce sequence-specific fragments but also
fragments that are specific for phosphate groups. These
phosphate-specific fragment ions serve as characteristic
'reporter ions' for phosphorylated peptides in precursor-
ion scanning experiments by MS/MS [58]. In the negative
ion mode phosphopeptides fragment produce marker
ions at m/z 79 (PO3
-) and 63 (PO2
-). CID of phosphoser-
ine- and phosphothreonine-containing peptides in the
positive ion mode often yields a neutral loss of H3PO4 via
β-elimination [67]. Peaks corresponding to this loss (98
from singly charged precursors, 49 from doubly charged
precursors, etc.) are often the most abundant ions in the
CID spectrum, although this is not invariably the case.
Phosphotyrosine residues do not undergo β-elimination
but do produce a characteristic immonium ion at m/z
216. Use of the characteristic immonium ion of phospho-
tyrosine was suggested as a possible marker for phospho-
tyrosine-containing peptides when using triple
quadrupole instruments [71-73]. However, because of the
possible number of other a, b, and y ions that give rise to
signals at the same nominal mass 216 [71,74], high-reso-
lution MS, such as a QSTAR Pulsar quadrupole time-of-
flight tandem mass spectrometer equipped with a nanoe-
lectrospray, are required to distinguish between the P-Tyr
immonium ion and those generated by other a, b, and y
ions [74,75]. Other methods use the negative-ion mode to
determine the more comprehensive phosphopeptide
composition of peptide mixtures by observing a fragment
at m/z 79 Da for phosphopeptides that contain P-Ser and/
or P-Thr [76,77]. A triple quadrupole mass spectrometer
operating in negative ion mode is generally used. In this
method, detection of the specific reporter ion identifies
the corresponding precursor phosphopeptide ion by its
mass to charge (m/z) value. In precursor ion scans, also
known as parent ion scans, only those peptides that frag-
ment to produce the chosen marker ion (m/z 79), pro-
duce peaks in the spectrum, screening out all other
species. Subsequent sequencing of the corresponding
phosphopeptide requires a change in polarity and re-buff-
ering of the sample, which implies that this system is not
readily amenable to liquid chromatography (LC)-MS-
based approaches. Despite these shortcomings, the
method is a powerful tool because of its high selectivity
and sensitivity and its applicability for serine, threonine
and tyrosine phosphorylated residues.
Neutral loss scanning
When peptides containing phosphoserine or phospho-
threonine residues are subjected to CID, they commonly
undergo a gas-phase β-elimination reaction, resulting in a
neutral loss of phosphoric acid (H3PO4, -98 Da) or are
dephosphorylated (HPO3, -80 Da). Phosphotyrosines,Proteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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however, are generally more resistant to this loss. Ideally,
precursor ion experiments can be performed on a triple
quadruple mass spectrometer with an offset to detect
phosphopeptide species that undergo such a loss. In the
MS/MS spectrum, a spacing of 69 Da (owing to dehy-
droalanine) or 83 Da (owing to dehydroaminobutyric
acid) indicates the exact location of phosphorylated serine
and threonine residues, respectively. For instance, using
this method, Wong et al. have identified three phosphor-
ylated sites in the cytosolic domain of calnexin (Ser 534,
Ser 544 and Ser 563) [78].
The drawbacks of this method are the incidence of false-
positive signals as well as the fact that the charge state of
the phosphopeptide has to be known in advance.
Emerging trends
Although Edman degradation and MS/MS using CID are
currently the methods of choice for sequencing phos-
phopeptides, alternatives have been demonstrated.
An alternative to these multi step procedures is data-
dependent analysis in the course of a single LC-MS exper-
iment [59,69,79]. Separation of tryptic peptides using LC
is an excellent way to decrease the complexity of the sam-
ple. In a variation of this technique, a 2D chromato-
graphic separation, first on a strong cation exchange and
then on a C18 column, has been performed [80]. Precur-
sor ion or neutral loss scanning is carried out until an ion
is detected above a pre-established intensity threshold.
The observed ion is then subjected to MS/MS to obtain its
sequence. Coupling of nanoLC systems to a mass spec-
trometer is valuable because separation of peptides by the
upfront LC step decreases the ion suppression effect
observed in the case of phosphopeptides.
Tandem mass spectrometry using electron capture dissoci-
ation has been also applied to phosphorylation site map-
ping [81]. This non-random technique favors
fragmentation of peptides along the peptide backbone;
Ser(P) and Thr(P) residues retain their phosphates, greatly
facilitating sequencing of the peptide and locating the
site(s) of phosphorylation.
Electron capture dissociation (ECD) combined with Fou-
rier transform ion cyclotron resonance (FTICR) MS has
emerged as a powerful method for the sequencing of pro-
teins and peptides as well as for the study of post-transla-
tional modifications [82]. It has also been successfully
applied for the exact localization of phosphorylated resi-
dues in peptides [83].
Recently, Aebersold and coworkers [84] described an
alternative general chemical strategy for the enrichment
and subsequent mass spectrometric analysis of phos-
phopeptides. This improvement consists in the direct cap-
ture of phosphopeptides in a single-step reaction with a
primary amine – containing solution polymer (in this
case, a Generation-5 polyamidoamine dendrimer) rather
than complicated chemical transformations. Selective
reaction of phosphorylated peptides with the amine
groups of the dendrimer produces phosphopeptide-poly-
mer conjugates that are physically larger than unmodified
peptides. Afterward, the phosphopeptides are released
from the dendrimer under acidic conditions, and isolated
from the dendrimer using the same membrane-based fil-
tration device [84].
Quantitative phosphoproteome analysis
Although defining the precise sites of phosphorylation
yields important information that can be related to the
biological function of phosphoproteins, the quantitative
evaluation of the extent of phosphorylation at a given site
or in relation to other phosphorylation sites, within the
same protein, is critical for the interpretation in terms of
biological significance. This is why quantitation of phos-
phorylation is particularly important. A given protein
might be in more than one signaling pathway with differ-
ent stimuli inducing overlapping patterns of phosphor-
ylation. That means a given site might not be
phosphorylated at all, phosphorylated in a minority of
molecules or, in an extreme case, on all the molecules of
that protein. When a population of molecules from
unsynchronized cells is analyzed, this situation corre-
sponds to detection of unphosphorylated, weakly phos-
phorylated or highly phosphorylated peptides containing
the residue. Similarly, the ratio of phosphorylation of a
protein on multiple residues might be crucial for its func-
tion.
Mass spectrometric approaches to quantitative phosphor-
ylation generally use stable isotope dilution whereby two
samples are differentially labeled with mass-encoded tags
such that the samples can be mixed and analyzed simulta-
neously. Each phosphopeptides thus appears as two peaks
in the mass spectrum, and the relative abundances of the
peaks reflect the amount of the phosphopetide in each
sample. This can be accomplished by metabolic labeling
of proteins in cell culture [85,86] or subsequent chemical
labeling of functional groups such as peptide N termini or
C termini [87-89]. In vitro labeling [13] is used to quanti-
tate proteins by labeling cysteine residue by a method des-
ignated isotope-coded affinity tagging (ICAT). A variation
to this strategy is to introduce a biotin tag into phospho-
serine and phosphothreonine residues by β-elimination
and Michael addition reaction [90]. Other methods take
advantage of this reaction for attaching different tags for a
quantitative analysis of phosphorylation without any
enrichment [90-92]. Several other methods that use
chemical moieties to make peptides heavier have alsoProteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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been developed [93-95]. Other methods use the treatment
with phosphatase in conjunction with isotopic labeling.
In this approach the quantitative phosphorylation in indi-
vidual samples is measured by dividing a sample in two,
labeling each with the light/heavy forms of a mass tag and
treating one sample with phosphatase before recombin-
ing the fractions [96,97]. An in vivo labeling has been used
to label yeast proteins by growing them 15N-labeled
media that labels all proteins without any further manip-
ulation and thus to quantitate the extent of phosphoryla-
tion [85]. An alternative approach to label proteins in vivo,
designated stable isotope labeling by amino acid in cell
culture (SILAC), which uses amino acid containing a sta-
ble isotope, has been developed [98].
The advantage of using stable-isotope containing amino
acids over media containing 15N is that it can be used in
cases where the sequence is not known. It is also possible
to couple in vitro and in vivo labeling methods, to quanti-
tate the phosphorylation, using 15N-labeling and a
method related to ICAT [99].
An alternative to labeling of phosphopeptides in vivo and
in vitro is to run two samples separately, each with the
same internal standard. The internal standard is a chemi-
cally synthesized heavier version of the phosphopeptide
being analyzed, allowing absolute quantitation of phos-
phorylation levels [100,101]. Although this method is
quite useful for small-scale analysis, it cannot be extended
to high-throughput experiments because it involves prior
knowledge of the phosphorylation site and production of
a synthetic peptide of each site.
Phosphoproteome validation
Some approaches have limitations in that phosphoryla-
tion sites may differ from what might take place within
the cell. Thus, data validation is particularly important for
phosphoproteins analysis. In this review, we provide two
major methodologies which allow for high throughput
validation of protein phosphorylation.
Proteome chip technology
Ptacek et al. [102] have developed assays to measure sub-
strate specificity in yeast directly at the level of kinase-sub-
strate interaction. This assay is highly selective because a
discrete set of substrates are recognized by each kinase.
Nonetheless, phosphorylations that do not normally
occur in vivo may be identified from this assay. These false
positives may be due to either in vitro phosphorylation of
proteins by kinases that normally reside in other cellular
compartments and/or are expressed at different times, or
through the absence of adaptor proteins that limit the
kinase-substrate interactions. Combining their data with
other information provides a useful method of detecting
interactions likely to occur in vivo. Thus, proteome chip
technology [103] offers many advantages for studying
protein phosphorylation.
Homogenous assays
AlphaScreen technology
The high throughput capability of the AlphaScreen tech-
nology can be used to detect and quantify phosphopep-
tides. Indeed, AlphaScreen is a bead-based non
radioactive and homogeneous detection technology. An
AlphaScreen signal is produced when the AlphaScreen
acceptor and donor beads are brought into close proxim-
ity by molecular interaction occurring between binding
partners captured on the beads mentioned above [104]. In
the case of phosphoprotein/peptide detection, the Donor
beads are functionalized using a specific antibody against
the protein of interest or Streptavidin. The Acceptor beads
are functionalized using either anti-PY antibodies or
Lewis Metal ions. AlphaScreen allows quantifying various
analyses by performing competition assays and extrapo-
lating signals with a standard curve. We have developed a
proteomic functional approach which combines both the
sensitivity of mass spectrometry sequencing to identify
phosphopeptides and the throughput of AlphaScreen for
validation of identified targets (Caruso et al., in prepara-
tion). Thus, the sensitivity of mass spectrometry sequenc-
ing coupled to the detection and throughput capacity of
the AlphaScreen technology allow identifying and validat-
ing the presence of phosphorylation sites in given pro-
teins.
IMAP technology
Similarly, in this assays fluorescently labeled peptides are
incubated with a kinase, the phosphorylated peptides
bind to the IMAP reagent (a trivalent metal with high
affinity for phosphates) causing an increase in the polari-
zation of the fluorescence [105].
Conclusion
Protein phosphorylation is one of the most challenging
posttranslational modifications to study, mainly due to
the low abundance and stoichiometry of this event. How-
ever, protein phosphorylation is critical for many cellular
processes, which therefore rely on the efficient addition or
removal of phosphate groups on specific amino acid resi-
dues (serine, threonine and tyrosine) of certain proteins.
The phosphoproteome consists of the entire complement
of phosphorylated proteins in cells, which is mapped or
analysed not only for the identification of phosphoryla-
tion sites, but also for the quantitation of phosphoryla-
tion events in signal transduction pathways in a time-
dependent manner. The analysis of the phosphoproteome
relies on techniques such as radioactive labeling, mass
spectrometry and Edman-sequencing, usually coupled to
upstream enrichment steps, which are used to increase the
amount of phosphorylated species in the monitoring step.Proteome Science 2006, 4:15 http://www.proteomesci.com/content/4/1/15
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Current techniques for the analysis of the phosphopro-
teome have been reviewed in this paper. Many advances
have been made on the enrichment and detection of
phosphoproteins, but these processes are still not straight-
forward for several reasons: the stoichiometry of phos-
phorylation is usually very low, the phosphorylated sites
on proteins vary, signalling molecules are present at low
abundance within cells, minor phosphorylation sites
might be difficult to identify due to a very limited
dynamic range of most analytical techniques to study
phosphorylation, and precautions need to be taken to
inhibit phosphatase activity during preparation and puri-
fication steps of cell lysates. The enrichment in phospho-
protein or phosphopeptide content, prior to the
respective analysis, circumvents some of the challenges
presented. Moreover, these approaches help to under-
stand the intricate cellular networks and regulation of
pathways, as well as identifying new proteins involved in
these processes that might reveal potential therapeutic
strategies.
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